BriaCell Therapeutics Corp.

(BCT:CX2)

By |

Profile

BriaCell Therapeutics Corp is an immuno oncology biotechnologu company with a focus on cancer immunotherapy. It has developed a patented whole-cell cancer vaccine, called the 'BriaVax' vaccine.

Contact Information

Website: www.briacell.com
Email: jwerbes@shaw.ca
Main Phone: +1 604 921-1810
Address: 235-15th Street
Address 2: Suite 300
State: BC
City / Town: West Vancouver
Country: CAN
Postal Code: V7T 2X1

Issuer Information

Exchange: CDX
CEO: William Williams
NAICS: Biological Product (except Diagnostic) Manufacturing(325414)
$ 0.13 $ 0. (0.00%)
Last Price 0.13 Change $ 0. Change % 0.00 Tick N/A
Bid N/A Bid Size 0.00 Ask N/A Ask Size 0.00
Open N/A High N/A Low N/A Prev Close 0.13
Last Trade Volume 0 52 Wk Hi 0.19 52 Wk Low 0.10
Market Cap 20.7 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 158,896,751.00 EPS (TTM) -0.07 PE Ratio N/A Exchange TSXV